Publications
- Classification of germline variants identified in cancer predisposition genetic testing - consensus of the CZECANCA consortium2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer2021 | First Faculty of Medicine
- Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients2021 | First Faculty of Medicine
- Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes2020 | First Faculty of Medicine, Central Library of Charles University
- Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer2020 | First Faculty of Medicine
- Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer2019 | First Faculty of Medicine
- Germline CHEK2 Gene Mutations in Hereditary Breast Cancer Predisposition - Mutation Types and their Biological and Clinical Relevance2019 | First Faculty of Medicine
- Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic2019 | First Faculty of Medicine
- Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes2018 | First Faculty of Medicine
- PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic2016 | First Faculty of Medicine
Loading network view...